| Literature DB >> 35571671 |
Fu-Sheng Liu1,2, Ke-Lu Li3, Yue-Ming He1,2, Zhong-Lin Zhang1,2, Yu-Feng Yuan1,2, Hai-Tao Wang1,2.
Abstract
Background: The liver cyst is commonly treated by hepatobiliary surgery. Generally, most patients show no apparent symptoms and often get diagnosed accidentally during the imaging examinations. In addition, most patients with liver cysts follow a benign course, with fewer severe complications and rare occurrences of malignant changes. Therefore, based on disease characteristics and healthcare costs, long-term regular follow-up of liver cysts are rarely performed clinically. Case Description: Here, we reported two previously treated or observed cases for liver cysts, where intrahepatic neoplastic lesions were found unexpectedly at the liver cyst during follow-up. These two patients' clinical manifestations and laboratory examinations lacked specificity with unclear pre-operative diagnosis, whereas the post-operative pathology confirmed cholangiocarcinoma. One of the patients was a 64-year-old female with right upper abdominal distension. She underwent cyst fenestration for a liver cyst 3 years ago. In the latest admission, imaging examination revealed a tumor in the left inner lobe of the liver. The tumor was located in the exact fenestration location, and the pathological diagnosis of cholangiocarcinoma was made after surgical resection. The patient received Lenvatinib post-operatively and had no recurrence during the follow-up. Another patient, a 68-year-old woman, was asymptomatic, but the liver margin was palpable under the ribs on her physical examination. She had a previous diagnosis of liver cysts and was on regular yearly follow-up. In the last follow-up, a tumor was found close to a cyst. It was diagnosed as intrahepatic cystadenocarcinoma before surgery; however, the pathological features after surgical resection were more consistent with the cholangiocarcinoma. The patient had lung metastases 2 months after the surgery, but her condition improved after receiving targeted therapy and immunotherapy. Moreover, she is alive to this day. Conclusions: We reported 2 cases of intrahepatic cholangiocarcinoma discovered accidentally during the follow-up of hepatic cysts. The location of the malignant tumor coincided with the location of the cyst, making the clinical differential diagnosis problematic. Therefore, it is necessary to be vigilant about the possibility of combined malignant tumors for the follow-up of complex cysts, as early detection and treatment may help improve the prognosis of these patients. After surgery, multimodal therapy, including chemotherapy, immunotherapy, and targeted therapy, is helpful. 2022 Translational Cancer Research. All rights reserved.Entities:
Keywords: Liver cysts; case report; intrahepatic cholangiocarcinoma
Year: 2022 PMID: 35571671 PMCID: PMC9091035 DOI: 10.21037/tcr-21-2373
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Imaging findings. Case 1: (A) multiple cysts in the liver; the cyst indicated by the white arrow has been fenestrated, and the site marked by the black circle was found to have a neoplastic lesion three years after the patient underwent fenestration of the liver cyst (CT, 2017/07/28); (B) a slightly low-density nodule by the black arrow with an unclear boundary in the liver’s left inner lobe (CT, 2020/09/15); (C) a marginally higher T2 signal shadow mixed in the left inner lobe as indicated by the white arrow (MRI, 2020/09/18). Case 2: (D) multiple cysts in the right lobe of the liver, about 42 mm × 36 mm in size (CT, 2017/08/20); (E) the size of the cyst increased about 49 mm × 45 mm (CT, 2019/08/30); (F) the liver’s right lobe showed a low-density shadow with a cross-sectional dimension of about 75 mm × 53 mm, and many low-density areas were seen inside the tumor (CT, 2020/09/02); (G-I) the MRI and PET/CT images at 2020/09/05. The white circles in (D,E) were the border of the hepatic cyst and the normal liver at examinations in 2017 and 2019, respectively. At the same location, a tumor adjacent to the anterior cysts indicated by the arrows in (F,G) was found at the follow-up examination in 2020. CT, computed tomography; MRI, magnetic resonance imaging.
Figure 2Gross examination of the resected specimen. (A) The tumor of case 1 was grayish/brown after the cut. (B) The resected tumor of case 2 was a solid cystic mass, and the inner wall was gray and smooth. The solid mass was grayish/white and dark/yellow in section, slightly stiff texture (each square side is 1 cm).
Figure 3Microscopic findings of the case 1 resected specimen. Hematoxylin and eosin staining: (A) bile duct cells formed the cyst wall. Tumor cells can be seen on the cyst wall and its surroundings, creating adenoid structures of different sizes, shapes, and irregular arrangements, some of which are arranged in clusters (×20, ×40); (B) the transition between neoplastic glands and dilated bile ducts (×40, ×100); (C) classic pathological image of cholangiocarcinoma: many tubular malignant glands with surrounding fibrous interstitial hyperplasia (×40, ×100).
Figure 4Microscopic findings of the case 2 resected specimen. Hematoxylin and eosin staining (×40, ×100): (A) visible cyst wall formed by bile duct cells, hyaline degeneration of the cyst wall, irregular glandular infiltrating growth around the cyst wall, interstitial fibrosis, mucus degeneration, and inflammatory cell infiltration; (B) tumorous glands invading the liver parenchyma. Immunohistochemistry (×100): (C) CK7 is diffusely positively expressed in the cytoplasm of bile duct cysts and neoplastic glandular epithelial cells; (D) CK19 is diffusely positively expressed in the cytoplasm neoplastic glandular epithelial cells and negatively expressed in the peripheral hepatocytes. CK7, cytokeratin 7; CK19, cytokeratin 19.
The clinical characteristics of the two cases
| Characteristics | Case 1* | Case 2* |
|---|---|---|
| Gender | Female | Female |
| Medical history | Liver cysts received cysts fenestration and drainage 3 years ago | Liver cysts, regular review, a solid lesion adjacent to the anterior cysts appeared in 1 year |
| Current information | ||
| Age, years | 64 | 66 |
| Adjacent cyst size, cross-sectional, cm2 | 6.8×6.8 | 4.8×4.3 |
| Cyst number | >3 | >3 |
| AST/ALT, U/L | 33/27 | 40/28 |
| TBIL/DBIL, μmol/L | 17.0/3.0 | 9.2/1.7 |
| PT/APTT, s | 12.3/40.3 | 12.5/28.4 |
| AFP/CEA, ng/mL | 5.90/3.05 | 1.63/5.98 |
| CA125, U/mL | 13.00 | 675.00 |
| CA153, U/mL | 10.30 | 38.22 |
| CA19-9, U/mL | <2.00 | 2,865.00 |
| Tumor size, cm3 | 5.0×3.6×3.4 | 7.0×6.0×4.5 |
| Tumor number | Single | Single |
| Tumor location | S4 | S6 |
| Treatment | Surgery & immunotherapy | Surgery & immunotherapy |
| Pathological diagnosis | Intrahepatic cholangiocarcinoma | Intrahepatic cholangiocarcinoma |
| Immunohistochemistry | ||
| AFP | – | + |
| Arginase | – | – |
| CD34 | – | – |
| CK7 | + | + |
| CK19 | + | + |
| Glypican-3 | – | – |
| Hepatocyte | – | – |
| Supplement | MUC1 (+), HSP70 (+) | Ki-67 (positive rate about 70%) |
| Portal vein invasion | – | – |
| Splenomegaly | – | – |
| Outcome | No progression after operation, survival | Post-operative lung metastasis, survival with tumor |
*, patients had no history of alcohol consumption, estrogen use, hepatolithiasis, or history of hepatitis B, hepatitis C infection. AFP, alpha-fetoprotein; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; CEA, carcinoembryonic antigen; CA125, carbohydrate antigen 125; CA153, carbohydrate antigen 153; CA19-9, carbohydrate antigen 19-9; CD34, cell antigen 34; CK19, cytokeratin 19; CK7, cytokeratin 7; DBIL, direct bilirubin; HSP70, heat shock protein 70; MUC1, mucoprotein 1; PT, prothrombin time; TBIL, total bilirubin.